H

ello, everyone, and how are you today? We are just fine, thank you, especially now that the Pharmalot campus has quieted down. The short person has long since left for the local schoolhouse and the official mascots have found comfy places to indulge their snoozing. As for us, we are busy foraging, as usual, for interesting items to pass along. On that note, here are some tidbits to help you get going. Hope your day is a successful one and you conquer the world. And of course, do keep in touch. We cherish your notes and calls …

AstraZeneca filed a lawsuit in a London court against a former executive, Luke Miels, for allegedly violating his employment agreement four months after he was hired by GlaxoSmithKline to run its pharmaceuticals business, Bloomberg News says. Last month, Glaxo said talks were under way to get Miels on board and hoped to reach a resolution soon. Miels was AstraZeneca’s executive vice president for Europe and is now on gardening leave (really?).

Unlock this article by subscribing to STAT Plus today. Try it FREE for 30 days and cancel anytime!

SUBSCRIBE TODAY

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

  • Selective bias. No one raised a “stink” when Williams and Williams Pharmaceuticals used a paid actor to promote their drug for inappropriate flatulence.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.